Development of liver fibrosis during aging: Effects of caloric restriction

Journal of Biological Regulators and Homeostatic Agents

Volumn 27, Issue 2, 2013, Pages 377-388

  Horrillo, D ^a   Gallardo, N ^b   Lauzurica, N ^a   Barrus M T ^a   San Frutos, M G ^a   Andres A ^b   Ros, M ^a   Fernández Agulló, Teresa ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b University of Castilla La Mancha   (Spain)

Author keywords

Elderly; Hepatic stellate cells; Lipid droplets; Non alcoholic fatty liver disease; Steatosis

Indexed keywords

COLLAGEN; FAT DROPLET; I KAPPA B; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P47; PROTEIN P50; PROTEIN P54; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; GLIAL FIBRILLARY ACIDIC PROTEIN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALORIC RESTRICTION; CELL STRUCTURE; COLLAGEN DEGRADATION; CONTROLLED STUDY; IMMUNOREACTIVITY; INFLAMMATION; LIVER FIBROSIS; LIVER HISTOLOGY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STELLATE CELL; ANIMAL; EXPERIMENTAL LIVER CIRRHOSIS; PHYSIOLOGY; WISTAR RAT;

AGING; ANIMALS; CALORIC RESTRICTION; GLIAL FIBRILLARY ACIDIC PROTEIN; HEPATIC STELLATE CELLS; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 84883480137     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Schmucker DL. Age-related changes in liver structure and function: Implications for disease? Exp Gerontol 2005; 40(8-9):650-9. (Pubitemid 41265815)
2. Gan L, Chitturi S, Farrell GC. Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly. Curr Gerontol Geriatr Res 2011; 2011:831536.
3. Horrillo D, Sierra J, Arribas C, et al. Age-associated development of inflammation in Wistar rats: Effects of caloric restriction. Arch Physiol Biochem 2011; 117(3):140-50.
4. Floreani A. Liver diseases in the elderly: an update. Dig Dis 2007; 25(2):138-43. (Pubitemid 46663780)
5. Fernandez-Galaz C, Fernandez-Agullo T, Perez C, et al. Long-term food restriction prevents ageing-associated central leptin resistance in wistar rats. Diabetologia 2002; 45(7):997-1003. (Pubitemid 34762194)
6. Hadler-Olsen E, Kanapathippillai P, Berg E, Svineng G, Winberg JO, Uhlin-Hansen L. Gelatin in situ zymography on fixed, paraffin-embedded tissue: zinc and ethanol fixation preserve enzyme activity. J Histochem Cytochem 2010; 58(1):29-39.
7. Gracia-Sancho J, Lavina B, Rodriguez-Vilarrupla A, et al. Increased oxidative stress in cirrhotic rat livers: A potential mechanism contributing to reduced nitric oxide bioavailability. Hepatology 2008; 47(4):1248-56. (Pubitemid 351547911)
8. Garcia-Sanfrutos M, Fernández-Agulló T, Carrascosa JM, et al. Involvement of protein tyrosine phosphatases and inflammation in hypothalamic insulin resistance associated with ageing: Effect of caloric restriction. Mech Ageing Dev 2012; 133:489-97.
9. Gard AL, White FP, Dutton GR. Extra-neural glial fibrillary acidic protein (GFAP) immunoreactivity in perisinusoidal stellate cells of rat liver. J Neuroimmunol 1985; 8(4-6):359-75. (Pubitemid 15025262)
10. Letteron P, Fromenty B, Terris B, Degott C, Pessayre D. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol 1996; 24(2):200-8. (Pubitemid 26059117)
11. Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120(5):1183-92. (Pubitemid 32246672)
12. Bergheim I, Guo L, Davis MA, Duveau I, Arteel GE. Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis. J Pharmacol Exp Ther 2006; 316(2):592-600. (Pubitemid 43130985)
13. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114(4):842-5.
14. Malaguarnera M, Di RM, Nicoletti F, Malaguarnera L. Molecular mechanisms involved in NAFLD progression. J Mol Med (Berl) 2009; 87(7):679-95.
15. Leyland H, Gentry J, Arthur MJ, Benyon RC. The plasminogen-activating system in hepatic stellate cells. Hepatology 1996; 24(5):1172-8. (Pubitemid 26365922)
16. Beier JI, Kaiser JP, Guo L, Martinez-Maldonado M, Arteel GE. Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosis. Arch Biochem Biophys 2011; 510(1):19-26.
17. Ueberham E, Low R, Ueberham U, Schonig K, Bujard H, Gebhardt R. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis. Hepatology 2003; 37(5):1067-78. (Pubitemid 36538683)
18. Gagliano N, Arosio B, Grizzi F, et al. Reduced collagenolytic activity of matrix metalloproteinases and development of liver fibrosis in the aging rat. Mech Ageing Dev 2002; 123(4):413-25. (Pubitemid 34024928)
19. Arthur MJ, Friedman SL, Roll FJ, Bissell DM. Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. J Clin Invest 1989; 84(4):1076-85. (Pubitemid 19247576)
20. Polyzos SA, Kountouras J, Zavos C. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med 2009; 9(3):299-314.
21. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000; 343(20):1467-76.
22. Carotti S, Morini S, Corradini SG, et al. Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C. Liver Transpl 2008; 14(6):806-14.
23. Blaner WS, O'Byrne SM, Wongsiriroj N, et al. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim Biophys Acta 2009; 1791(6):467-73.
24. Kluwe J, Wongsiriroj N, Troeger JS, et al. Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis. Gut 2011; 60(9):1260-8.
25. Fortuna VA, Trugo LC, Borojevic R. Acyl-CoA: retinol acyltransferase (ARAT) and lecithin: retinol acyltransferase (LRAT) activation during the lipocyte phenotype induction in hepatic stellate cells. J Nutr Biochem 2001; 12(11):610-21. (Pubitemid 33035933)
26. Warren A, Cogger VC, Fraser R, Deleve LD, McCuskey RS, Le Couteur DG. The effects of old age on hepatic stellate cells. Curr Gerontol Geriatr Res 2011; 2011:439835.
27. Yamaguchi K, Yang L, McCall S, et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 2007; 45(6):1366-74. (Pubitemid 46918320)
28. Ikejima K, Takei Y, Honda H, et al. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology 2002; 122(5):1399-410. (Pubitemid 34465182)
29. Allman M, Wallace M, Gaskin L, Rivera CA. Leptin induces an inflammatory phenotype in lean Wistar rats. Mediators Inflamm 2009; 2009:738620.
30. Lo L, McLennan SV, Williams PF. Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis. J Hepatol 2011; 55(2):435-44.